Viewmax: $503 MRR from an AI video studio, per payment data on TrustMRR
TrustMRR pulls this revenue from Dodo Payments. Viewmax is an AI video studio for YouTube Shorts, ads and social clips.
Subject: ViewmaxCredits and paid plans
Case Overview & Background
Viewmax and is an AI video studio for YouTube Shorts, ads and social clips. The listing gives a founding date of 2026-02-23. TrustMRR shows $574 in the last 30 days, $503 MRR, $9,005 all-time revenue, 24 active subscriptions as of November 2, 2026.
How AI Is Used
Step-by-Step Process
The business focuses on one outcome: an AI video studio for YouTube Shorts, ads and social clips.
Pricing on the listing: Free to start with credits, Paid plans available.
Revenue is shared publicly through a Dodo Payments connection on TrustMRR.
Customer Acquisition & Distribution
Limitations, Risks & Failure Modes
What may not apply to you, and what could go wrong:
- Revenue is not profit; AI model, hosting and marketing costs are not shown
- Figures change daily; this is a snapshot from November 2, 2026
- Products built on third-party AI models depend on those providers' pricing and policies
Key Takeaways
- A narrow AI product or service with a clear outcome can be sold directly to consumers or businesses
- Payment-provider-verified figures are stronger than screenshots but are still not an audit
Sources
TrustMRR verified revenue page: Viewmax
Note: Revenue pulled from Dodo Payments. Viewed November 2, 2026. Product description on the page is written by the founder.
Category page banner: Reach readers researching one specific AI business model.
One clearly labelled banner on a category page such as Micro-SaaS or AI Agencies, shown next to the documented cases your product is relevant to.
Sponsored placements are always labelled and never change how cases are researched, labelled, or ranked.
Commercial disclosure: We currently have no affiliate or sponsorship relationship with any tool or person on this page. If that changes, affiliate links and sponsored content will be clearly labelled, and evidence labels will never be changed for commercial reasons.
